In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Petar Seferovic
Speaker
Petar Seferovic
Petar Seferovic Petar Seferovic

Belgrade University, Faculty of Medicine, Belgrade (Serbia)

Specialities : Chronic Heart Failure , Acute Heart Failure, Myocardial Disease

• President, Heart failure Association of the ESC • Academician, Serbian Academy of Sciences and Arts • Professor of Internal Medicine, University of Belgrade School of Medicine • Professor, Heart Failure Center, Belgrade University Medical Center • President, Heart Failure Society of Serbia Coauthored 606 publications, with cumulative impact factor of 1078 (h-index 36), including multiple papers in peer-reviewed international journals. He has a total citation of 17833 (Google Scholar) / 14298 (Scopus). He presented more than 260 lectures at International conferences.

51 presentations from this speaker

Experts on the Spot: Cardiac remodelling and outcomes.

Event : HFA Discoveries 2020

  • Session : Experts on the Spot: Cardiac remodelling and outcomes
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsored by Novartis Pharma AG

Introduction

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS)
  • Sponsorered by Novartis Pharma AG

Optimal Implementation of HF Therapies: guidelines and challenges.

Event : Webinar 2020

  • Session : HFA Webinars 2020
  • Speaker : P Ponikowski (Wroclaw,PL), A Coats (Warwickshire,GB), P Seferovic (Belgrade,RS)

Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?

Event : HFA Discoveries 2020

  • Session : Reversing cardiac remodelling and improving outcomes in heart failure: what are our first-choice treatments?
  • Speaker : CS Lam (Singapore,SG), P Seferovic (Belgrade,RS), W Mullens (Genk,BE), M Guazzi (San Donato Milanese,IT)
  • Sponsorered by Novartis Pharma AG

SGLT-2 inhibitors in heart failure: beyond glycaemic control.

Event : HFA Discoveries 2020

  • Session : SGLT-2 inhibitors in heart failure: beyond glycaemic control
  • Speaker : R De Boer (Groningen,NL), P Seferovic (Belgrade,RS)

SGLT-2 inhibitors in the treatment of heart failure: the future is bright?

Event : HFA Discoveries 2020

  • Session : SGLT-2 inhibitors in heart failure: beyond glycaemic control
  • Speaker : P Seferovic (Belgrade,RS)

Comprehensive positioning of sacubitril/valsartan in optimizing patient outcomes.

Event : ESC Congress 2019

  • Session : Update on novel therapeutic approaches in heart failure
  • Speaker : P Seferovic (Belgrade,RS)
  • Heart Failure Association (HFA)

Conclusion

Event : ESC Congress 2019

  • Session : The heart failure patient's journey: key learning and objectives
  • Speaker : P Seferovic (Belgrade,RS)
  • Sponsored by Servier

Dilated cardiomyopathy: what's new?

Event : Heart Failure 2019

  • Session : Heart failure in cardiomyopathies: differences in diagnosis and management
  • Speaker : P Seferovic (Belgrade,RS)

Endomyocardial biopsy: research application and future perspectives.

Event : Heart Failure 2019

  • Session : Global position paper on endomyocardial biopsy in cardiovascular medicine
  • Speaker : P Seferovic (Belgrade,RS)
  • Joint Session with the Heart Failure Society of America (HFSA) and the Japanese Heart Failure Society (JHFS)

Glucose-lowering drugs and heart failure.

Event : ESC Congress 2019

  • Session : 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the European Association for the Study of Diabetes (EASD)
  • Speaker : P Seferovic (Belgrade,RS)

Heart failure - Diagnosis and classification.

Event : ESC Congress 2019

  • Session : Chronic heart failure: Essential Update
  • Speaker : P Seferovic (Belgrade,RS)

Hyperkalaemia and heart failure therapy: maximising RAASi.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : M Lainscak (Murska Sobota,SI), GMC Rosano (London,GB), P Seferovic (Belgrade,RS)

Introduction - An update on device technologies in heart failure.

Event : Heart Failure 2019

  • Session : An update on device technologies in heart failure
  • Speaker : P Seferovic (Belgrade,RS)
  • Sponsored by Medtronic

Introduction - Optimizing the heart failure patients’ pathway right from the discharge.

Event : Heart Failure 2019

  • Session : Optimizing the heart failure patients’ pathway right from the discharge
  • Speaker : P Seferovic (Belgrade,RS)
  • Sponsored by SERVIER

Mechanical circulatory support - Advanced heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : T Ben Gal (Ramat Hasharon,IL), M Frigerio (Milan,IT), P Seferovic (Belgrade,RS)

Miscellaneous.

Event : Heart Failure 2019

  • Session : HFA General Assembly
  • Speaker : P Seferovic (Belgrade,RS)

Opening address.

Event : Heart Failure 2019

  • Session : Inaugural Session
  • Speaker : P Seferovic (Belgrade,RS)

Optimisation of heart failure treatment after discharge.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : L Hill (Co.Antrim,GB), R Hobbs (Oxford,GB), M Metra (Brescia,IT), P Seferovic (Belgrade,RS)

Panel discussion about clinical cases - Optimizing the heart failure patients’ pathway right from the discharge.

Event : Heart Failure 2019

  • Session : Optimizing the heart failure patients’ pathway right from the discharge
  • Speaker : P Liu (Ottawa,CA), A Coats (Warwickshire,GB), P Seferovic (Belgrade,RS)
  • Sponsored by SERVIER

President's Report

Event : Heart Failure 2019

  • Session : HFA General Assembly
  • Speaker : P Seferovic (Belgrade,RS)

Questions & Answers .

Event : Heart Failure 2019

  • Session : HFA General Assembly
  • Speaker : P Seferovic (Belgrade,RS)

Sacubitril/valsartan.

Event : Heart Failure 2019

  • Session : Chronic heart failure: optimising patient management
  • Speaker : P Seferovic (Belgrade,RS)

SGLT-2 inhibitors.

Event : Heart Failure 2019

  • Session : Emerging treatment options in HFpEF
  • Speaker : P Seferovic (Belgrade,RS)

The heart failure patient's journey - Questions and answers

Event : ESC Congress 2019

  • Session : The heart failure patient's journey: key learning and objectives
  • Speaker : A Coats (Warwickshire,GB), P Seferovic (Belgrade,RS)
  • Sponsored by Servier

Therapeutic advances for patients with heart failure and diabetes.

Event : Heart Failure 2019

  • Session : A crosstalk between diabetes and heart failure
  • Speaker : P Seferovic (Belgrade,RS)

Therapeutic approach to HFpEF.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : J Bauersachs (Hannover,DE), P Seferovic (Belgrade,RS), M Senni (Bergamo,IT)

Update on the management of HFpEF.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : J Bauersachs (Hannover,DE), P Seferovic (Belgrade,RS), M Senni (Bergamo,IT)

Up-to-date management of diabetic patients with heart failure.

Event : Webinar 2019

  • Session : HFA Webinars 2019
  • Speaker : A Coats (Warwickshire,GB), GMC Rosano (London,GB), P Seferovic (Belgrade,RS)

Welcome from the President of the HFA.

Event : Heart Failure 2019

  • Session : Inaugural Session
  • Speaker : P Seferovic (Belgrade,RS)

Acute heart failure and type 2 diabetes

Event : Heart Failure 2018

  • Session : Diabetes and heart failure - A 21st century global challenge
  • Speaker : P Seferovic (Belgrade,RS)

Antidiabetics drugs

Event : Heart Failure 2018

  • Session : Novel drugs in heart failure
  • Speaker : P Seferovic (Belgrade,RS)

Conclusion - Optimizing heart failure treatments before discharge.

Event : Heart Failure 2018

  • Session : Optimizing heart failure treatments before discharge
  • Speaker : P Seferovic (Belgrade,RS)
  • Sponsored by SERVIER

Diabetes and heart failure

Event : ESC Congress 2018

  • Session : Gaps in evidence - How to proceed when the Heart Failure Guidelines do not provide a definite answer
  • Speaker : P Seferovic (Belgrade,RS)

Diabetes in heart failure: past and future

Event : Heart Failure 2018

  • Session : Acute heart failure -From drugs to devices and back
  • Speaker : P Seferovic (Belgrade,RS)
  • Joint session with the Japanese Heart Failure Society and the Heart Failure Society of America

Glucose lowering and beyond.

Event : ESC Congress 2018

  • Session : Cardiovascular prevention in diabetes
  • Speaker : P Seferovic (Belgrade,RS)
  • European Association of Preventive Cardiology (EAPC)

HFA Board 2018-2020.

Event : Heart Failure 2018

  • Session : HFA General Assembly
  • Speaker : P Seferovic (Belgrade,RS)

Introduction - Optimized heart failure care throughout the patient journey.

Event : ESC Congress 2018

  • Session : Optimized heart failure care throughout the patient journey
  • Speaker : P Seferovic (Belgrade,RS)
  • Sponsored by SERVIER

Panel discussion.

Event : Heart Failure 2018

  • Session : Functional mitral and tricuspid regurgitation: will novel transcatheter options redefine the landscape?
  • Speaker : W Abraham (Columbus,US), S Anker (Berlin,DE), F Maisano (Zurich,CH), U Schaefer (,DE), ML Enriquez-Sarano (Rochester,US), P Seferovic (Belgrade,RS)
  • Organised by Charité Berlin, supported with an educational grant by Edwards Lifesciences

Phenotypic polymorphism in myocarditis

Event : Heart Failure 2018

  • Session : The many faces of myocarditis
  • Speaker : P Seferovic (Belgrade,RS)

Understanding the diabetic heart - State of the art

Event : ESC Congress 2018

  • Session : Heart failure: the nemesis of Diabetes
  • Speaker : P Seferovic (Belgrade,RS)

Definition and classification.

Event : Heart Failure 2017

  • Session : Differential diagnosis of dilated cardiomyopathy
  • Speaker : P Seferovic (Belgrade,RS)

Diabetes-related cardiomyopathy.

Event : Heart Failure 2017

  • Session : Hot topics in diabetes and heart failure
  • Speaker : P Seferovic (Belgrade,RS)

Teams' presentation.

Event : Heart Failure 2017

  • Session : HFA Championships
  • Speaker : P Seferovic (Belgrade,RS)

Treatment of diabetes in patients with heart failure: advice for the cardiologist

Event : ESC Congress 2017

  • Session : Heart failure patients tend to have more than one problem: how to manage comorbidities
  • Speaker : P Seferovic (Belgrade,RS)

A deadly intersection: why?

Event : Heart Failure 2015

  • Session : Diabetes and heart failure: double jeopardy
  • Speaker : P Seferovic (Belgrade,RS)

Diabetes.

Event : Heart Failure 2015

  • Session : Co-morbidities in acute heart failure
  • Speaker : P Seferovic (Belgrade,RS)

Heart Failure and diabetes.

Event : ESC Congress 2015

  • Session : Heart failure 2015: update for the clinician
  • Speaker : P Seferovic (Belgrade,RS)

Peri-partum cardiomyopathy.

Event : Acute Cardiovascular Care 2015

  • Session : Pregnancy and acute cardiovascular care
  • Speaker : P Seferovic (Belgrade,RS)

Diabetic and endocrine-related cardiomyopathies.

Event : ESC Congress 2013

  • Session : Dilated cardiomyopathies in systemic disorders
  • Speaker : P Seferovic (Belgrade,RS)

Panel.

Event : ESC Congress 2013

  • Session : Invasive techniques in pericardial disease
  • Speaker : Y Adler (Rannana,IL), E Arbustini (Pavia,IT), B Maisch (Marburg,DE), A Ristic (Belgrade,RS), P Seferovic (Belgrade,RS)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are